tiprankstipranks
Lipigon Pharmaceuticals AB (DE:9RP)
FRANKFURT:9RP
Germany Market
9RP
Lipigon Pharmaceuticals AB
RESEARCH TOOLSreports

Lipigon Pharmaceuticals AB (9RP) Financial Statements

0 Followers

Lipigon Pharmaceuticals AB Financial Overview

Lipigon Pharmaceuticals AB's market cap is currently €323.21K. The company's EPS TTM is €-0.001103592; its P/E ratio is -0.11; Lipigon Pharmaceuticals AB is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 0.00kr 10.29Mkr 16.41Mkr 390.00Kkr 3.18M
Gross Profitkr -83.00Kkr -26.29Mkr -5.12Mkr 366.00Kkr -36.04M
Operating Incomekr -31.77Mkr -25.58Mkr -12.37Mkr -37.74Mkr -41.19M
EBITDAkr -31.68Mkr -25.14Mkr -12.10Mkr -37.68Mkr -41.09M
Net Incomekr -32.44Mkr -25.26Mkr -12.13Mkr -37.67Mkr -41.12M
Balance Sheet
Cash & Short-Term Investmentskr 10.21Mkr 11.78Mkr 31.93Mkr 9.64Mkr 28.47M
Total Assetskr 11.49Mkr 14.82Mkr 33.60Mkr 10.82Mkr 29.43M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -10.21Mkr -11.78Mkr -31.93Mkr -9.64Mkr -28.47M
Total Liabilitieskr 3.57Mkr 7.06Mkr 5.16Mkr 6.95Mkr 6.47M
Stockholders' Equitykr 7.91Mkr 7.76Mkr 28.45Mkr 3.87Mkr 22.96M
Cash Flow
Free Cash Flowkr -35.88Mkr -25.02Mkr -14.32Mkr -37.47Mkr -35.42M
Operating Cash Flowkr -35.77Mkr -24.78Mkr -14.32Mkr -37.47Mkr -35.30M
Investing Cash Flowkr -108.00Kkr -235.00Kkr 0.00kr 0.00kr -119.00K
Financing Cash Flowkr 34.32Mkr 4.58Mkr 36.70Mkr 18.61Mkr 51.09M
Currency in SEK

Lipigon Pharmaceuticals AB Earnings and Revenue History

Income Statement >

Lipigon Pharmaceuticals AB Debt to Assets

Balance Sheet >

Lipigon Pharmaceuticals AB Cash Flow

Cash Flow >

Lipigon Pharmaceuticals AB Forecast EPS vs Actual EPS

Earnings >